Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Amit K. Vijapura"'
Autor:
Vishaal Mehra, James L. Andersen, Michael J. Biunno, Jelena Kunovac, Walter Ling, Barbara R. Haight, Saleem Ishaque, David R. Hassman, Gregory Seal, Scott Daniel Segal, Amanda S. Garofalo, Jesse M. Carr, Valentin Isacesu, Rakesh Ranjan, Ricky Stuart Mofsen, Otto R. Dueno, Kent Steven Hoffman, Paul J. Fudala, Brent Boyett, Shishuka Malhotra, Lawrence S. Levinson, Céline M. Laffont, Peter Paul Ventre, Eduardo Cifuentes, Sandra Daniela Duarte-Sckell, Scott Robert Bartley, Genie L. Bailey, Richard D. Knapp, Gita G. Pujari, Kyle M. Kampman, Rajinder Shiwach, Christian Heidbreder, Vijay R Nadipelli, Daniel Rutrick, Y Zhao, Rishi Kakar, Katharina Wiest, Marvin Lane Peyton, David P. Walling, Susan M Learned, Joseph A. Kwentus, Amit K. Vijapura, Haydn Mikel Thomas, Boyde J. Harrison, Mark K. Greenwald, George Konis
Publikováno v:
The Lancet. 393:778-790
RBP-6000, referred to as BUP-XR (extended-release buprenorphine), is a subcutaneously injected, monthly buprenorphine treatment for opioid use disorder. BUP-XR provides sustained buprenorphine plasma concentrations to block drug-liking of abused opio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d956456416ef2fa898c563ec73fed86b
https://doi.org/10.1016/s0140-6736(18)32259-1
https://doi.org/10.1016/s0140-6736(18)32259-1
